Who we are
We are an international umbrella liver patient-led association. Our purpose is to represent and advocate for all patients affected by liver disease in both policy and operational contexts and promote equal access to effective areas of liver healthcare.
What we do
We undertake activities to improve care and treatment for people who are affected by, or at the risk, of a liver condition. We work in a progressive and collaborative way, ensuring meaningful engagement and partnerships with other stakeholders.
Become a member
Together we will be able to support, develop and lead increased patient support and advocacy, playing a crucial role in shaping the policy of global
health strategies and initiatives through partnerships.
Our network
NEOLIVER
Board member José Willemse is a member of the advisory board of NEOLVIER, an...
GRIPonMASH (EU project)
Liver Patients International is a partner in the EU project GRIPonMASH....
Fantastic document about Public health from Ireland
The Irish Public health organisation released this document. It explains what...
Research news from Takeda Alpha 1 Antitrypsin. Learn more about the Alpha 1 Liver Disease!
If you or any of your family members have a confirmed or suspected diagnosis...
EASL has a weekly broadcast with interesting subjects for patient organisations.
EASL has a weekly broadcast with interesting subjects for patient...
PBC Master Sequence Video
Sunday 14 September is International PBC day! Join us and click on the video!
World Hepatitis Summit 28 -30 April 2026 in Bangkok Thailand
https://worldhepatitissummit.org/ Are you planning to attend? Please contact...
EASL Congress 27 – 30 May 2026
From 27-30 May, Fira, Barcelona, Spain will be the home of hepatology! The...
Innovations in Steatotic Liver Disease
The People-First Liver Charter Is Out! ISGlobal took initiative to publish...
Key messages of World Hepatitis Summit 2024
World Hepatitis Summit 2024 was hosted in Lisbon, Portugal on 9-11 April as an...










